We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

CELLAVISION AB

Handheld Multiplexed Biosensor Platform Tests Antibodies, Antigens and Molecular Targets Simultaneously

By LabMedica International staff writers
Posted on 30 May 2023

A pioneering, portable, multiplex biosensor platform has the ability to simultaneously test antibodies, antigens, and molecular targets, enabling handheld, laboratory-grade testing wherever required - from emergency rooms to battlefields. This rugged, cost-effective, portable, user-friendly reader comprises a single-use biochip equipped with 32 graphene-based sensors. Each sensor can be individually configured to identify molecular, antigen, and antibody targets. This effectively puts a whole lab in the palm of the hand, allowing healthcare professionals to make timely decisions wherever needed and simplifying work processes with results available within minutes.

The HemBox biosensor system from Hememics Biotechnologies (Gaithersburg, MD, USA) is a handheld, robust, and environmentally durable analytical device desigend for rapid on-site detection. It can test for bio-hazards in water, soil, and infected individuals. Capable of identifying multiple biothreats simultaneously, the HemBox provides sensitive, selective, and measurable data in real-time. This data can be stored on the device and transferred once a Bluetooth-enabled device with a secure user account comes within range.


Image: HemBox is an iPhone-sized POC Bluetooth-enabled, immunosensor tool that delivers sensitive, selective, and measurable results in minutes (Photo courtesy of Hememics)
Image: HemBox is an iPhone-sized POC Bluetooth-enabled, immunosensor tool that delivers sensitive, selective, and measurable results in minutes (Photo courtesy of Hememics)

The HemBox works with HemChip, a multiplexed immuno-biosensor that delivers rapid, affordable, and real-time disease biomarker measurements anywhere in the world. This compact, portable, and disposable biosensor, configured for multiplexing, comes with a bioreceptor layer and a proprietary biochip, designed to detect pathogens swiftly and accurately with high sensitivity. Each HemChip integrates multiple biosensors to detect several pathogens simultaneously. Working together, the HemBox and HemChip interpret the signals emitted by the HemChip, providing the user with real-time test results in less than five minutes.

“I am extremely proud of what the company has achieved with the limited amount of resources,” said John Warden, Jr., CEO and Co-founder of Hememics Biotechnologies, Inc. “We have generated extremely favorable results from more than 100,000 biosensor experiments in the past nine months.”

Related Links:
Hememics Biotechnologies 


New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Latest Molecular Diagnostics News

Blood-Based Test Outperforms Ultrasound in Early Liver Cancer Detection

Four-In-One Molecular Test Detects and Differentiates Among Most Prevalent Respiratory Viruses in 20 Minutes

First-Line PSA Testing More Cost-Effective Than First-Line MRI for Prostate Cancer Screening



LGC Clinical Diagnostics